Measles Research and Vaccine
Dive | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
|
Dive | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
|
In 1963, Dr. John Enders and colleagues, who had transformed the Edmonston-B strain of the measles virus to a vaccine, got it licensed in the United States.
In 1968, an improved and weaker measles vaccine, created by Maurice Hilleman and colleagues began to be distributed in the United States. This vaccine was called the Edmonston-Enders (formerly Moraten) strain and has been the only vaccine used in the United States since.
The measle vaccine is usually combined with the mumps and rubella vaccine (MMR) and sometimes with the varicella vaccine (MMRV).
Measles research at the NIH was in the Laboratory of Virology and Rickettsiology in Building 29, but the entire lab moved to Building 29A in 1967 when the annex opened.
Gallery
Dive | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
|